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Context
• Research indicates that pharmacy performance in supplying non-prescription medicines (NPM) is often suboptimal1.
• A previous case study2, suggests the need of exploring an organizational approach to quality improvement.
• Organizational culture has been poorly investigated in community pharmacy3.
Aim
The study aims to address this existing knowledge gap by developing
and testing a managerial instrument – a Balanced Score Card (BSC) –
for the quality supply of NPM.
Methods
Discussion
Tackling the quality of non-prescription 
medicines dispensing in pharmacies by 
combining a Balanced Score Card with 
change management: interim findings
Results
References:
[1] Xu T., Neto A.C.A. and Moles R.J. (2012) “A systematic review of simulated-patient methods used in community pharmacy to assess the provision of non-prescription medicines” Int
J Pharm Pract, 20. pp. 307-19. [2] Veiga P., Lapão L.V., Cavaco A.M. and Guerreiro M.P. (2015) “Quality supply of nonprescription medicines in Portuguese community pharmacy: an 
exploratory case study” Res Social Adm Pharm, 11(6). pp 880-90. [3] Jacobs S., Ashcroft D. and Hassel K. (2011) “Culture in community pharmacy organisations: what can we glean 
from the literature?” J Health Organ Manag, 25(4). pp 420-54. [4] Lapão L.V. (2011) “Gestão de Unidades de Saúde”.
• Exploratory sample size, as usual in “proof of concept” studies
Four to six pharmacies with different characteristics
(currently three)
• Purposive sampling
Location (urban, suburban and rural);
Number of staff (as a proxy for pharmacy turnover).
• These characteristics are relevant to ensure variability in the conditions
under which the BSC will be developed and tested.
• Thirteen indicators were initially identified relating to four essential BSC
perspectives4:
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Preliminary results from three pharmacies indicate a high
customer satisfaction:
• 93% Satisfaction reported by the phone questionnaire (73
customer responses);
• 88% Satisfaction reported by phone with the proposed
pharmaceutical intervention to their minor ailment.
Overall, professional satisfaction at baseline was high (83%).
At the baseline the dominant culture type in the pharmacies was
clan, as it can be observed in the graphics.
Pharmacy A Pharmacy B
In the first months of BSC testing there was an increase in NPM 
margins, even when sales were lower comparing with homologous 
months.
Pharmacy interventions and recruited customers, evolved in the 
following way: Month 1 (A=17; B=18), Month 2 (A=4; B=1), Month 
3 (A=4; B=2), Month 4 (A=3; B=12), Month 5 (A=4; B=4) and      
Month 6 (A=15; B=8).
Staff commitment to the study waned after the first month, improving in the last, creating difficulties in data collection. This can be attributed to lack of
time and staff shortages. On the positive side, BSC testing has enabled a better understanding of the mechanisms associated with the quality supply
of NPM. Estimated study duration in each pharmacy is 6 months. After this period, focus groups with consenting pharmacy staff will be conducted.
This will allow more in-depth exploration of staff’s views on the usefulness and applicability of BSC as a quality improvement tool in NPM dispensing.
